Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese Adult Male”

66 trials

Showing 20 of 66 results

Testing effectiveness (Phase 2)Study completedNCT04677660
What this trial is testing

TAK-919 in Healthy Japanese Adults (COVID-19)

Who this might be right for
Coronavirus Disease (COVID-19)
Takeda 200
Testing effectiveness (Phase 2)Study completedNCT04712110
What this trial is testing

TAK-019 in Healthy Japanese Adults (COVID-19)

Who this might be right for
Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Takeda 200
Early research (Phase 1)Study completedNCT04451083
What this trial is testing

Multiple-dose Study of FOY-305 in Japanese Healthy Adult Male Subjects

Who this might be right for
Healthy Volunteers
Ono Pharmaceutical Co., Ltd. 14
Early research (Phase 1)Study completedNCT02537457
What this trial is testing

Bioequivalence Study of Rivaroxaban

Who this might be right for
Embolism, Atrial Fibrillation and Venous Thrombosis
Bayer 40
Early research (Phase 1)Study completedNCT02927353
What this trial is testing

Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects

Who this might be right for
Healthy Volunteer
Meiji Seika Pharma Co., Ltd. 180
Early research (Phase 1)Study completedNCT00224783
What this trial is testing

Phase I Trial Evaluating Safety and Tolerability of CAIV-T in Healthy Japanese Male Adults

Who this might be right for
Healthy Japanese Male Adults
MedImmune LLC 45
Early research (Phase 1)Study completedNCT02354599
What this trial is testing

Single-Dose Study of MT203

Who this might be right for
Healthy Volunteers
Takeda 32
Early research (Phase 1)Study completedNCT01506752
What this trial is testing

A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy Japanese Adult Males

Who this might be right for
Healthy Adult
Eisai Co., Ltd. 20
Post-approval studies (Phase 4)Study completedNCT02530060
What this trial is testing

Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 8
Early research (Phase 1)Study completedNCT03074058
What this trial is testing

Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet

Who this might be right for
Clinical Pharmacology
Bayer 20
Early research (Phase 1)Study completedNCT03922633
What this trial is testing

A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants

Who this might be right for
Healthy Male Participants
EA Pharma Co., Ltd. 24
Early research (Phase 1)Study completedNCT04791332
What this trial is testing

JNJ-67953964 in Healthy Japanese Adult Male Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 30
Early research (Phase 1)Study completedNCT04878471
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male Participants

Who this might be right for
Healthy Volunteers
Astellas Pharma Inc 12
Testing effectiveness (Phase 2)Study completedNCT00280384
What this trial is testing

An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects

Who this might be right for
Spasmodic Torticollis
Eisai Limited 48
Early research (Phase 1)Study completedNCT04511637
What this trial is testing

Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on the Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 15 mg in Japanese Healthy Male Adult Subjects

Who this might be right for
Clinical Pharmacology
Bayer 80
Early research (Phase 1)WithdrawnNCT02322606
What this trial is testing

A Phase 1, Single and Multiple Dose Study of TAK-137

Who this might be right for
Healthy Japanese Adult Male
Takeda
Early research (Phase 1)Study completedNCT06453551
What this trial is testing

A Phase I Study of TRN501 in Healthy Volunteers

Who this might be right for
Parkinson Disease
SNLD, Ltd. 72
Early research (Phase 1)Study completedNCT01081821
What this trial is testing

Single and Multiple Dose Study to Explore the Safety and Pharmacokinetics of JNJ-39758979 In Healthy Male Volunteers of Either Caucasian or Japanese Descent

Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 61
Early research (Phase 1)Study completedNCT00385489
What this trial is testing

Study Evaluating LXR-623 in Healthy Japanese Adults

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer
Early research (Phase 1)Study completedNCT04511611
What this trial is testing

Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 10 mg in Japanese Healthy Male Adult Subjects

Who this might be right for
Clinical Pharmacology
Bayer 80
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation